Mar 16
NICE Draft Guidance Proposes Treatment Options For Psoriatic Arthritis
Arthritis / Rheumatology No Comments »
The National Institute for Health and Clinical Excellence (NICE) has published draft guidance recommending etanercept (Enbrel, Wyeth Pharmaceuticals) and adalimumab (Humira, Abbott Laboratories) for the treatment of adults with active and progressive psoriatic arthritis when specific criteria are met...
